- Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
-
Kwok SK
- KMID: 1794621
- Korean J Intern Med.
- 2014 Sep;29(5):577-579.
- doi: 10.3904/kjim.2014.29.5.577
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
-
Kim JW, Choi IA, Lee EY, Song YW, Lee EB
- KMID: 1793016
- J Korean Med Sci.
- 2013 Aug;28(8):1134-1138.
- doi: 10.3346/jkms.2013.28.8.1134
Tofacitinib, a novel Janus kinase inhibitor, may prevent structural damage in rheumatoid arthritis (RA). In this cohort study, we compared radiographic progression of hand joints between 21 RA patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial
-
Min SK, Rhee CS, Kim CE, Kang DY
- KMID: 1729607
- Yonsei Med J.
- 1993 Jun;34(2):179-190.
- doi: 10.3349/ymj.1993.34.2.179
A parallel group double-blind comparative trial was conducted to study the efficacy and safety of risperidone compared with haloperidol. After a one-week wash-out, 35 chronic schizophrenic patients (17 males, 18... -
- CITED
-
- Close
- SHARE
-
- Close
